Thomas Bourgeron
Professor
University Paris Diderot
From this contributor
Expliquer la résilience à l’autisme peut faire naître de nouvelles thérapies
Explaining ‘resilience’ in autism may seed new therapies
Some individuals who have autism mutations show no signs of the condition; understanding why may lead to treatments.
Explaining ‘resilience’ in autism may seed new therapies
Questions for Thomas Bourgeron: In search of ‘second hits’
Taking a close look at people who have a mutation in a known autism gene may reveal why these people often have vastly different characteristics.
Questions for Thomas Bourgeron: In search of ‘second hits’
Explore more from The Transmitter
Remembering GABA pioneer Edward Kravitz
The biochemist, who died last month at age 92, was part of the first neurobiology department in the world and showed that gamma-aminobutyric acid is inhibitory.
Remembering GABA pioneer Edward Kravitz
The biochemist, who died last month at age 92, was part of the first neurobiology department in the world and showed that gamma-aminobutyric acid is inhibitory.
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.
Protein tug-of-war controls pace of synaptic development, sets human brains apart
Human-specific duplicates of SRGAP2 prolong cortical development by manipulating SYNGAP, an autism-linked protein that slows synaptic growth.
Neurons tune electron transport chain to survive onslaught of noxious stimuli
Nociceptors tamp down the production of reactive oxygen species in response to heat, chemical irritants or toxins.
Neurons tune electron transport chain to survive onslaught of noxious stimuli
Nociceptors tamp down the production of reactive oxygen species in response to heat, chemical irritants or toxins.